Health Care

Bio-Path’s stock tanks as company delivers loss for Q1

May 16, 2019

Titan Pharmaceuticals posts wider-than-expected Q1 loss

May 15, 2019

Johnson & Johnson set to revitalize pharma biz; eyes ‘above-market’ growth

May 15, 2019

Aurora Cannabis’ net loss widens in Q3

May 14, 2019

Aurinia Pharmaceuticals loss narrowed in Q1; AURORA trial on track

May 14, 2019

Tilray Q1 loss widens, meets estimates

May 14, 2019

Earnings: Agilent stock falls on Q2 earnings miss, weak guidance

May 14, 2019

Solid Biosciences tumbles 38% to hit historic low

May 14, 2019

Earnings: Catabasis Q1 loss narrows on lower expenses, beats estimates

May 14, 2019

InspireMD Q1 revenues plunge on third-party equipment failure

May 14, 2019

CorMedix reports upbeat Q1 results; provides business update

May 13, 2019

Catalyst Pharmaceuticals’ Q1 results beat estimates

May 13, 2019

Aurora Cannabis Q3 earnings: What’s in the cards?

May 12, 2019

Earnings preview: Agilent braces for an upbeat Q2 amid stable demand

May 10, 2019

ESSA Pharma posts narrower loss in Q2

May 10, 2019

Earnings: Ocular Therapeutix Q1 loss widens on higher R&D expenses

May 10, 2019

Corbus Pharma’s Q1 results fall short of expectations

May 9, 2019

Cronos Group starts off fiscal 2019 with a profit in Q1

May 9, 2019

Portola’s stock crashes 12% despite Q1 results beat

May 8, 2019

Intercept Pharmaceuticals reports mixed Q1 results

May 8, 2019

Cara Therapeutics Q1 loss widens but beats estimates

May 7, 2019